Listen: Talkspace’s civic experiment, Illumina’s FTC headache, & remembering Gilead’s John Martin
Can an app replace in-person therapy? Is Illumina too big to Grail? And is another CRISPR patent dispute in the cards? Find out on the latest episode of "The Readout…
